MX2009000569A - Ensayo y kit para predecir el exito de la implantacion en la fertilizacion asistida. - Google Patents

Ensayo y kit para predecir el exito de la implantacion en la fertilizacion asistida.

Info

Publication number
MX2009000569A
MX2009000569A MX2009000569A MX2009000569A MX2009000569A MX 2009000569 A MX2009000569 A MX 2009000569A MX 2009000569 A MX2009000569 A MX 2009000569A MX 2009000569 A MX2009000569 A MX 2009000569A MX 2009000569 A MX2009000569 A MX 2009000569A
Authority
MX
Mexico
Prior art keywords
assay
kit
assisted fertilisation
implantation success
fertilisation
Prior art date
Application number
MX2009000569A
Other languages
English (en)
Inventor
Nathalie Ledee
Marie-Pierre Piccinni
Raoul Lombroso
Original Assignee
Mithra Pharmaceuticals Nv Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mithra Pharmaceuticals Nv Sa filed Critical Mithra Pharmaceuticals Nv Sa
Publication of MX2009000569A publication Critical patent/MX2009000569A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un ensayo para determinar el potencial de implantación de una pluralidad de embriones, cada uno obtenido o que va a ser obtenido por fertilización asistida de un oocito de un sujeto femenino, que comprende medir los niveles del factor estimulador de colonias de granulocitos (G-CSF) en el fluido folicular (FF) presente en el folículo del cual es derivado cada oocito, y determinar el potencial de implantación de cada embrión a partir del nivel del FF G-CSF medido. Éste también se refiere a un kit para llevar a cabo el ensayo. Ésta se refiere además a un método para la fertilización asistida.
MX2009000569A 2006-07-21 2007-07-18 Ensayo y kit para predecir el exito de la implantacion en la fertilizacion asistida. MX2009000569A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83209406P 2006-07-21 2006-07-21
PCT/EP2007/057430 WO2008009705A1 (en) 2006-07-21 2007-07-18 Assay and kit for predicting implantation success in assisted fertilisation

Publications (1)

Publication Number Publication Date
MX2009000569A true MX2009000569A (es) 2009-06-19

Family

ID=38529962

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009000569A MX2009000569A (es) 2006-07-21 2007-07-18 Ensayo y kit para predecir el exito de la implantacion en la fertilizacion asistida.

Country Status (21)

Country Link
US (1) US8211650B2 (es)
EP (5) EP3267198B1 (es)
JP (1) JP5052609B2 (es)
KR (2) KR20140040289A (es)
CN (2) CN101495871A (es)
AT (1) ATE468538T1 (es)
AU (1) AU2007275112B2 (es)
BR (1) BRPI0714494B1 (es)
CA (1) CA2658665C (es)
DE (1) DE602007006672D1 (es)
DK (2) DK2049906T3 (es)
EA (1) EA016348B1 (es)
ES (4) ES2345571T3 (es)
HK (2) HK1128760A1 (es)
HR (2) HRP20100382T8 (es)
MX (1) MX2009000569A (es)
MY (1) MY150687A (es)
NZ (1) NZ574135A (es)
PL (2) PL2214021T3 (es)
PT (2) PT2214021E (es)
WO (1) WO2008009705A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2198876T3 (da) 2003-10-24 2013-03-11 Nora Therapeutics Inc Fremgangsmåde til nedsættelse af sandsynligheden for implantationssvigt i et individ
US8338373B2 (en) 2003-10-24 2012-12-25 Nora Therapeutics, Inc. Method for reducing the risk of spontaneous abortion in a human female subject
US20090226397A1 (en) 2003-10-24 2009-09-10 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
US9176145B2 (en) 2006-07-21 2015-11-03 Femalon S.P.R.L. Kit for predicting implantation success in assisted fertilization
GB0806281D0 (en) * 2008-04-07 2008-05-14 Univ Leeds Markers of Oocyte viability
CA2720651C (en) 2008-05-01 2020-03-10 Zymogenetics, Inc. Levels of blys/april heterotrimers in serum and use in diagnostic methods
WO2010126528A1 (en) * 2009-05-01 2010-11-04 Nora Therapeutics, Inc. Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination
US20120196316A1 (en) * 2009-06-25 2012-08-02 Phase Holographic Imaging Phi Ab Analysis of ova or embryos with digital holographic imaging
WO2011000805A1 (en) 2009-06-29 2011-01-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarkers of oocyte competency and method of use
US9753042B2 (en) 2013-04-23 2017-09-05 Rosalind Franklin University Of Medicine And Science Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination procedures
EP3126836A4 (en) * 2014-04-02 2017-11-08 Prince Henry's Insitute of Medical Research Trading as The Hudson Institute of Medical Research A prognostic assay for succes of assisted reproductive technology
CN104450904A (zh) * 2014-12-02 2015-03-25 柳州市妇幼保健院 利用颗粒细胞端粒长度来判断胚胎发育潜能的方法
WO2017054038A1 (en) 2015-09-30 2017-04-06 Prince Henry's Institute Of Medical Research Trading As The Hudson Institute Of Medical Research A method of treatment and prognosis
CN110361534B (zh) * 2018-03-26 2023-11-03 山大生殖研发中心有限公司 评估胚胎和预测体外受精成功率的化学标记物和其应用
RU2746644C1 (ru) * 2021-01-21 2021-04-19 Мекан Рахимбердыевич Оразов Способ оценки имплантационной состоятельности эндометрия при повторных неудачах имплантации, ассоциированных с хроническим эндометритом

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
NZ228482A (en) 1988-03-24 1991-03-26 Terrapin Tech Inc Chromatography substrate containing a peptide paralog (active site mimicer) peptide
JP3058673B2 (ja) * 1989-11-10 2000-07-04 株式会社明電舎 サイトカインの測定方法及びその測定用キット
GB9603326D0 (en) * 1996-02-16 1996-04-17 Royal Free Hosp School Med Predictive assay
JP5271481B2 (ja) * 1999-09-08 2013-08-21 中外製薬株式会社 タンパク質溶液製剤およびその安定化方法
US6555660B2 (en) * 2000-01-10 2003-04-29 Maxygen Holdings Ltd. G-CSF conjugates
AU2002325819B2 (en) 2001-07-11 2008-06-19 Maxygen, Inc. G-CSF Conjugates

Also Published As

Publication number Publication date
EP2214021B1 (en) 2015-01-07
JP2009544934A (ja) 2009-12-17
KR101482568B1 (ko) 2015-01-14
EP2214021A1 (en) 2010-08-04
HK1128760A1 (en) 2009-11-06
EA016348B1 (ru) 2012-04-30
HRP20150251T1 (en) 2015-06-05
US8211650B2 (en) 2012-07-03
JP5052609B2 (ja) 2012-10-17
CA2658665A1 (en) 2008-01-24
NZ574135A (en) 2011-11-25
EP2049906B1 (en) 2010-05-19
US20090312596A1 (en) 2009-12-17
EP3267198A1 (en) 2018-01-10
EP3627156A1 (en) 2020-03-25
KR20090056986A (ko) 2009-06-03
BRPI0714494A2 (pt) 2013-05-14
HK1208529A1 (en) 2016-03-04
CN106199004B (zh) 2019-04-09
DE602007006672D1 (de) 2010-07-01
HRP20100382T8 (en) 2010-10-31
ES2634527T3 (es) 2017-09-28
CA2658665C (en) 2017-09-26
EP2049906A1 (en) 2009-04-22
ES2754707T3 (es) 2020-04-20
CN101495871A (zh) 2009-07-29
KR20140040289A (ko) 2014-04-02
ES2531853T3 (es) 2015-03-20
EP2857840B8 (en) 2017-08-02
AU2007275112A1 (en) 2008-01-24
BRPI0714494B1 (pt) 2018-05-08
PL2214021T3 (pl) 2015-06-30
HRP20100382T1 (hr) 2010-08-31
EA200900210A1 (ru) 2009-06-30
MY150687A (en) 2014-02-28
AU2007275112B2 (en) 2012-07-12
ATE468538T1 (de) 2010-06-15
CN106199004A (zh) 2016-12-07
EP3267198B1 (en) 2019-09-04
ES2345571T3 (es) 2010-09-27
PT2214021E (pt) 2015-03-11
EP2857840A1 (en) 2015-04-08
PT2049906E (pt) 2010-08-02
WO2008009705A1 (en) 2008-01-24
DK2049906T3 (da) 2010-07-05
DK2214021T3 (en) 2015-02-16
PL2049906T3 (pl) 2010-10-29
EP2857840B1 (en) 2017-06-14

Similar Documents

Publication Publication Date Title
MY150687A (en) Assay and kit for predicting implantation success in assisted fertilisation
NZ598293A (en) Imaging and evaluating embryos, oocytes, and stem cells
IT1391619B1 (it) Metodo per l'individuazione, selezione e analisi di cellule tumorali
DE602007004771D1 (de) Verfahren zur quantitativen cDNA-Analyse in Einzelzellen
ATE522627T1 (de) Verfahren zur herstellung von nukleinsäuresonden
ATE375518T1 (de) Diagnoseverfahren für erkrankungen unter verwendung von copeptin
BR112013033348A2 (pt) meios e processos para a determinação de modelos de previsão associados com um fenótipo
WO2011156734A3 (en) Method of characterizing vascular diseases
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
WO2009125219A3 (en) Markers of oocyte viability
IT1393648B1 (it) Metodo per l'ottenimento di piante transgeniche resistenti all'attacco di fitopatogeni basato sull'interferenza dell'rna (rnai)
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
CL2008002118A1 (es) Metodo para la produccion de un embrion equino de sexo seleccionado mediante la inyeccion intracitoplasmatica de esperma utilizando espermatozoides de equino seleccionados por sexo.
GB201016616D0 (en) Method and system for determining characteristics of an embryo and uses thereof
EP1987165A4 (en) Gene with influence on the human memory
MY148542A (en) A method for the assessment of cancer in a biological sample obtained from a subject
DE602005027414D1 (de) Verfahren zur übertragung episomaler vektoren in tierzellen
RU2008115714A (ru) Ингибитор 8-оксогуанин-днк-гликозилазы человека
TW200728471A (en) Probe set, kit and method for sex determination of bovine or ovine cells
DE502005011007D1 (de) Verwendung von fettalkoholpolyglykolethersulfaten für die emulsionspolymerisation
UA94479C2 (ru) Способ определения стадии эструса у норок клеточного разведения
PL2109361T3 (pl) Transgeniczne zwierzę i sposób jego otrzymywania
TH134782B (th) วิธีเพื่อแสดงเอกลักษณ์องค์ประกอบที่ปรับเปลี่ยนการแสดงออกของยีนและโปรตีน ไวลต์ไทป์ในเซลล์พืช
TH124016A (th) การถ่ายภาพและการประเมินเอมบริโอ (embryos), เซลล์เพศ (oocytes) และสเต็มเซลล์ (stem cells)
WO2009047274A3 (en) Ptpl1 as a biomaker of survival in breast cancer

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights